Cargando…

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India

Efficacy and safety data on quadrivalent influenza vaccines (QIVs) for immunization of Indian children are scarce. This phase 3, registration study evaluated the immunogenicity, safety, and tolerability of a QIV in Indian children aged 6–35 months (Group 1) and 3–17 y (Group 2). Subjects received on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalappanavar, Nijalingappa K., Ghosh, Apurba, Sharma, Monika, Ravichandran, Latha, Choraria, Nirmal, P, Saravanan, Pandey, Madhukar, N, Pradeep, Shah, Prachee, Nair, Sneha, Shaikh, Ashfaque, van de Witte, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Influenza – Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746468/ https://www.ncbi.nlm.nih.gov/pubmed/36053721 http://dx.doi.org/10.1080/21645515.2022.2104527

Ejemplares similares

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
por: Wei, Xia, et al.
Publicado: (2023)

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
por: Chen, Jianmin, et al.
Publicado: (2023)

Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
por: Hadigal, Sanjay, et al.
Publicado: (2022)

Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study
por: Basu, Indraneel, et al.
Publicado: (2021)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis
por: Bianculli, Pablo Manuel, et al.
Publicado: (2022)

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay
por: Arbo, Antonio, et al.
Publicado: (2022)

Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial
por: Huang, Xiaoyuan, et al.
Publicado: (2022)

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study
por: Fan, Renfeng, et al.
Publicado: (2021)

Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system
por: Betancourt-Cravioto, Miguel, et al.
Publicado: (2021)

Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
por: Nurpeisova, Ainur, et al.
Publicado: (2022)

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?
por: Raude, Jocelyn, et al.
Publicado: (2010)

Identification of Influenza Cases During the H1N1 Pandemic in Massachusetts Using Population-Based Hospital Discharge Data
por: Placzek, Hilary, et al.
Publicado: (2011)

Applying a New Model for Sharing Population Health Data to National Syndromic Influenza Surveillance: DiSTRIBuTE Project Proof of Concept, 2006 to 2009
por: Olson, Donald R, et al.
Publicado: (2011)

Prevalence and risk factors for swine influenza virus infection in the English pig population
por: Mastin, Alexander, et al.
Publicado: (2011)

Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
por: Fedichev, Peter, et al.
Publicado: (2011)

Top-hits for H1N1pdm Identified by Virtual Screening Using Ensemble-based Docking
por: Nguyen, Hung, et al.
Publicado: (2011)

The severity of pandemic H1N1 influenza in the United States, April – July 2009
por: Presanis, Anne M, et al.
Publicado: (2010)

Next Generation Syndromic Surveillance: Molecular Epidemiology, Electronic Health Records and the Pandemic Influenza A (H1N1) Virus
por: Rabadan, Raul, et al.
Publicado: (2009)

Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza
por: Le, Ly, et al.
Publicado: (2011)

Can Reactive School Closures help critical care provision during the current influenza pandemic?
por: House, Thomas, et al.
Publicado: (2009)

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza
por: Ross, Ted, et al.
Publicado: (2010)

Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity
por: Chowell, Gerardo, et al.
Publicado: (2012)

Recovery of H14 influenza A virus isolates from sea ducks in the Western Hemisphere
por: Nolting, Jacqueline, et al.
Publicado: (2012)

Influenza activity in Saint Joseph, Missouri 1910-1923: Evidence for an early wave of the 1918 pandemic
por: Hoffman, Brian L.
Publicado: (2011)

Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA.
por: Ross, Ted M., et al.
Publicado: (2011)

Swine to human transmission of reassortants of pandemic (H1N1) 2009 and endemic swine influenza viruses: Abstract
por: de Silva, U. Chandimal, et al.
Publicado: (2011)

Fatal cases associated with pandemic influenza A (H1N1) reported in Greece.
por: Athanasiou, Maria, et al.
Publicado: (2010)

VirSim - a Model to Support Pandemic Policy Making
por: Fasth, Tobias, et al.
Publicado: (2010)

Weekly influenza-like-Illness rates were significantly lower in areas where schools were not in session in the United States during the 2009 H1N1 pandemic.
por: Briffault, Olivia
Publicado: (2011)

Critical paths in a metapopulation model of H1N1: Efficiently delaying influenza spreading through flight cancellation
por: Marcelino, Jose, et al.
Publicado: (2012)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

The early diversification of influenza A/H1N1pdm
por: Nelson, Martha, et al.
Publicado: (2009)

Quantifying the transmissibility of human influenza and its seasonal variation in temperate regions
por: Truscott, James, et al.
Publicado: (2010)

Public preparedness guidance for a severe influenza pandemic in different countries: a qualitative assessment and critical overview
por: Alonso, Wladimir J., et al.
Publicado: (2010)

Efficient simulation of the spatial transmission dynamics of influenza
por: Tsai, Meng-Tsung, et al.
Publicado: (2010)

Absolute Humidity and the Seasonal Onset of Influenza in the Continental US
por: Shaman, Jeffrey, et al.
Publicado: (2010)

Seasonal Influenza Vaccine Allocation in the Canadian Population during a Pandemic
por: Tuite, Ashleigh, et al.
Publicado: (2009)

Tempo and Mode in the Molecular Evolution of Influenza C
por: Gatherer, Derek
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_07qfkq0hqo10j1p1qo63tvag5a